What is a HeartMate II LVAD?

The HeartMate II™ Left Ventricular Assist Device (LVAD) provides short or long-term circulatory support for intermediate-to-advanced heart failure patients. This small, quiet pump features a simple design — with only one moving part — and can provide blood flow equivalent to that of a healthy heart.

Is HeartMate 3 approved for destination therapy?

Abbott (NYSE:ABT) said today it won FDA approval for its HeartMate 3 left ventricular assist device, now approved as a destination therapy for patients with advanced heart failure.

What is LVAD medical term?

A left ventricular assist device (LVAD) is implanted in your chest. It helps pump blood from the left ventricle of your heart and on to the rest of your body. A control unit and battery pack are worn outside your body and are connected to the LVAD through a port in your skin.

How many LVADs are implanted each year?

The population eligible for the implantation of such devices is reduced; there are currently fewer than 200 implantations per year.

Who makes the HeartMate II?

Abbott Medical
Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

Responsible Party: Abbott Medical Devices
ClinicalTrials.gov Identifier: NCT00121472 History of Changes
Other Study ID Numbers: TC010230-1
First Posted: July 21, 2005 Key Record Dates
Results First Posted: March 19, 2013

How does HeartMate II work?

HeartMate II is designed to take over the pumping function of the patient’s left ventricle. The device is placed just below the diaphragm in the abdomen. It is attached to the left ventricle, and the aorta, the main artery that carries oxygenated blood from the left ventricle to the entire body.

How long can a person live with a LVAD?

Left ventricular assist device (LVAD) is usually used to keep a patient alive until a suitable heart donor is found. A patient may stay alive for 5 and a half years with LVAD. As per research, 80–85% of patients are alive a year after having an LVAD placed and 70–75% of patients are alive for 2 years with an LVAD.

When was HeartMate III FDA approved?

The HeartMate 3 pump was initially approved in the United States in 2017 for adults awaiting a heart transplant and received FDA approval for long-term use in adults in 2018.

How long can you survive with an LVAD?

What is the most common type of ventricular assist device?

The LVAD is the most common type of VAD. It helps the left ventricle pump blood to the aorta. The aorta is the main artery that carries oxygen-rich blood from your heart to your body. RVADs usually are used only for short-term support of the right ventricle after LVAD surgery or other heart surgery.

What is the difference between HeartMate 2 and 3?

The HeartMate 3 device is a pulsatile-flow system without mechanical bearings, as opposed to the HeartMate II device which is a continuous-flow system with mechanical bearings which has carried the burden of hemocompatibility related complications, including pump thrombosis, stroke, and gastrointestinal bleeding.